AbstractHere it is described nanogels (NG) based on a chitosan matrix, which are covalently stabilized by a bisamide derivative of Mn‐t‐CDTA (t–CDTA = trans‐1,2‐diaminocyclohexane‐N,N,N′,N′‐tetraacetic acid). the Mn(II) complex acts both as a contrast medium and as a cross‐linking agent. These nanogels are proposed as an alternative to the less stable paramagnetic nanogels obtained by electrostatic interactions between the polymeric matrix and paramagnetic Gd(III) chelates. The present novel nanogels show: i) relaxivity values seven times higher than that of typical monohydrated Mn(II) chelates at the clinical fields, thanks to the combination of a restricted mobility of the complex with a fast exchange of the metal‐bound water molecule; ii) high stability of the formulation over time at pH 5 and under physiological conditions, thus excluding metal leaking or particles aggregation; iii) good extravasation and accumulation, with a maximum contrast achieved at 24 h post‐injection in mice bearing subcutaneous breast cancer tumor; iv) high T₁ contrast (1 T) in the tumor 24 h post‐injection. These improved properties pave the way for the use of these paramagnetic nanogels as promising magnetic resonance imaging (MRI) probes for in vitro and in vivo preclinical applications.